{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:02:17Z","timestamp":1792454537770,"version":"4.5.0"},"reference-count":44,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Risk Analysis"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This introduction for the third special issue on modeling poliovirus risks provides context for the current status of global polio eradication efforts and gives an overview of the individual papers included in the issue. Although risk analysis continues to support the Global Polio Eradication Initiative (GPEI), efforts to finish the job remained off track at the beginning of 2020 and prior to the COVID\u201019 pandemic, as discussed in the special issue. The disruptions associated with COVID\u201019 occurring now will inevitably change the polio eradication trajectory, and future studies will need to characterize the impacts of these disruptions on the polio endgame.<\/jats:p>","DOI":"10.1111\/risa.13668","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T18:42:43Z","timestamp":1613673763000},"page":"223-228","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Modeling and Managing Poliovirus Risks: We are Where we are\u2026"],"prefix":"10.1111","volume":"41","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[{"name":"Kid Risk Inc.  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13669"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12962"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.026"},{"issue":"389","key":"e_1_2_5_5_1","article-title":"An economic analysis of poliovirus risk management policy options for 2013\u20132052","volume":"15","author":"Duintjer Tebbens R. J.","year":"2015","journal-title":"BMC Infectious Diseases"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1506333"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13194"},{"key":"e_1_2_5_8_1","unstructured":"Global Polio Eradication Initiative. (2015 September 20).Global eradication of wild poliovirus type 2 declared. Retrieved fromhttp:\/\/www.polioeradication.org\/mediaroom\/newsstories\/Global-eradication-of-wild-poliovirus-type-2-declared\/tabid\/526\/news\/1289\/Default.aspx"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0791-5"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13214"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idm.2018.06.001"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13485"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13555"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13590"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13193"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13590"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13664"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13471"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13486"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13447"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba1238"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13580"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00853.x"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12030"},{"key":"e_1_2_5_25_1","article-title":"Poliovirus vaccine options: Another step forward","author":"Thompson K. M.","year":"2020","journal-title":"Lancet"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.864563"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix128"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13671"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13614"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1635463"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13557"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13484"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1791093"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13665"},{"key":"e_1_2_5_35_1","unstructured":"World Health Assembly. (1988).Global eradication of poliomyelitis by the year 2000 (resolution 41.28). Retrieved fromhttp:\/\/www.who.int\/csr\/ihr\/polioresolution4128en.pdf"},{"key":"e_1_2_5_36_1","unstructured":"World Health Organization. (2016).Three years with no wild poliovirus type 3 \u2010 November 10 2015. Retrieved fromhttp:\/\/polioeradication.org\/news-post\/three-years-with-no-wild-poliovirus-type-3\/"},{"key":"e_1_2_5_37_1","unstructured":"2017 World Health Organization Report on polio transition planning \u2010 advance draft as of 18 April 2017"},{"key":"e_1_2_5_38_1","unstructured":"World Health Organization. (2019a).Report from the Twentieth Meeting of the Global Commission for Certification of Poliomyelitis Eradication Geneva Switzerland 17 \u2014 18 October 2019. Retrieved fromhttp:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/20th-meeting-of-the-Global-Commission-for-the-Certification-of-Eradication-of-Poliomyelitis-17-18-October-2019.pdf"},{"key":"e_1_2_5_39_1","unstructured":"World Health Organization. (2019b).Two out of three wild poliovirus strains eradicated. Retrieved fromhttps:\/\/www.who.int\/news-room\/feature-stories\/detail\/two-out-of-three-wild-poliovirus-strains-eradicated"},{"key":"e_1_2_5_40_1","unstructured":"World Health Organization. (2020a).Africa kicks out wild polio. Retrieved fromhttps:\/\/polioeradication.org\/news-post\/africa-kicks-out-wild-polio\/"},{"key":"e_1_2_5_41_1","unstructured":"World Health Organization. (2020b).Polio this week as of 9 December 2020. Retrieved fromhttp:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/"},{"key":"e_1_2_5_42_1","unstructured":"World Health Organization Global Polio Eradication Initiative. (2013).Polio eradication and endgame Strategic Plan (2013\u20102018).Geneva; 2013. Report No: WHO\/POLIO\/13.02. Retrieved fromhttp:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf"},{"key":"e_1_2_5_43_1","unstructured":"World Health Organization Global Polio Eradication Initiative. (2015).Polio eradication & endgame: Midterm review July 2015.Geneva; 2015. Report No: WHO\/POLIO\/15.04. Retrieved fromhttp:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/GPEI-MTR_July2015.pdf"},{"key":"e_1_2_5_44_1","unstructured":"World Health Organization Global Polio Eradication Initiative. (2019).Polio eradication and endgame strategic plan (2019\u20102023).Geneva; 2019. Report No: WHO\/POLIO\/19.04. Retrieved fromhttp:\/\/polioeradication.org\/wp-content\/uploads\/2019\/05\/polio-endgame-strategy-2019-2023.pdf"},{"key":"e_1_2_5_45_1","unstructured":"World Health Organization Global Polio Eradication Initiative. (2020).Strategy for the response to type 2 circulating vaccine\u2010derived poliovirus 2020\u20132021: Addendum to the Polio eradication and endgame strategic plan (2019\u20102023).Geneva; 2020. Report No: WHO\/POLIO\/20.02. Retrieved fromhttp:\/\/polioeradication.org\/wp-content\/uploads\/2020\/04\/Strategy-for-the-response-to-type-2-circulating-Vaccine-Derived-Poliovirus-20200406.pdf"}],"container-title":["Risk Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/risa.13668","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/risa.13668","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/risa.13668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:55:18Z","timestamp":1693684518000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/risa.13668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1111\/risa.13668"],"URL":"https:\/\/doi.org\/10.1111\/risa.13668","archive":["Portico"],"relation":{},"ISSN":["0272-4332","1539-6924"],"issn-type":[{"value":"0272-4332","type":"print"},{"value":"1539-6924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"2020-05-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}